nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A case of linear immunoglobulin A bullous dermatosis in a patient exposed to sun and an analgesic
|
Pellicano, Riccardo |
|
2009 |
31 |
Part 1 |
p. 1987-1990 4 p. |
artikel |
2 |
A comparison of a standard-dose prednisone regimen and mycophenolate mofetil combined with a lower prednisone dose in chinese adults with idiopathic nephrotic syndrome who were carriers of hepatitis B surface antigen: A prospective cohort study
|
Li, Xiayu |
|
2009 |
31 |
Part 1 |
p. 741-750 10 p. |
artikel |
3 |
A comparison of insulin use, glycemic control, and health care costs with insulin detemir and insulin glargine in insulin-naive patients with type 2 diabetes
|
Borah, Bijan J. |
|
2009 |
31 |
Part 1 |
p. 623-631 9 p. |
artikel |
4 |
A multicenter, randomized, double-blind, placebo- controlled trial of intravenous ibuprofen 400 and 800 mg every 6 hours in the management of postoperative pain
|
Southworth, Stephen |
|
2009 |
31 |
Part 1 |
p. 1922-1935 14 p. |
artikel |
5 |
Analysis of the North Carolina Long-Term Care Polypharmacy Initiative: A multiple-cohort approach using propensity-score matching for both evaluation and targeting
|
Trygstad, Troy K. |
|
2009 |
31 |
Part 1 |
p. 2018-2037 20 p. |
artikel |
6 |
An evidence-based assessment of the clinical significance of drug-drug interactions between disease-modifying antirheumatic drugs and non-antirheumatic drugs according to rheumatologists and pharmacists
|
van Roon, Eric N. |
|
2009 |
31 |
Part 1 |
p. 1737-1746 10 p. |
artikel |
7 |
An open-label, single-dose, parallel-group, dose-increasing study comparing the pharmacokinetics and tolerability of pilsicainide hydrochloride in healthy Korean and Japanese male subjects
|
Kim, Bo-Hyung |
|
2009 |
31 |
Part 1 |
p. 609-618 10 p. |
artikel |
8 |
An oral sulfonylurea in the treatment of transient neonatal diabetes mellitus
|
Loomba-Albrecht, Lindsey A. |
|
2009 |
31 |
Part 1 |
p. 816-820 5 p. |
artikel |
9 |
Anthracycline- and/or taxane-resistant breast cancer: Results of a literature review to determine the clinical challenges and current treatment trends
|
Moreno-Aspitia, Alvaro |
|
2009 |
31 |
Part 1 |
p. 1619-1640 22 p. |
artikel |
10 |
Antidiabetic medication use and prevalence of chronic kidney disease among patients with type 2 diabetes mellitus in the United States
|
Koro, Carol E. |
|
2009 |
31 |
Part 1 |
p. 2608-2617 10 p. |
artikel |
11 |
Antipsychotics and antidepressants: An analysis of cost growth in finland from 1999 to 2005
|
Koskinen, Hanna |
|
2009 |
31 |
Part 1 |
p. 1469-1477 9 p. |
artikel |
12 |
A pharmacokinetic comparison of single doses of once-daily cyclobenzaprine extended-release 15 mg and 30 mg: A randomized, double-blind, two-period crossover study in healthy volunteers
|
Darwish, Mona |
|
2009 |
31 |
Part 1 |
p. 108-114 7 p. |
artikel |
13 |
A randomized, controlled study comparing a lidocaine patch, a placebo patch, and anesthetic injection for treatment of trigger points in patients with myofascial pain syndrome: Evaluation of pain and somatic pain thresholds
|
Affaitati, Giannapia |
|
2009 |
31 |
Part 1 |
p. 705-720 16 p. |
artikel |
14 |
A randomized, double-blind clinical study to assess the antimicrobial effects of a cetylpyridinium chloride mouth rinse on dental plaque bacteria
|
Hu, Deyu |
|
2009 |
31 |
Part 1 |
p. 2540-2548 9 p. |
artikel |
15 |
A review of efficacy and safety data regarding the use of liraglutide, a once-daily human glucagon-like peptide 1 analogue, in the treatment of type 2 diabetes mellitus
|
Montanya, Eduard |
|
2009 |
31 |
Part 1 |
p. 2472-2488 17 p. |
artikel |
16 |
A review of the efficacy of desloratadine, fexofenadine, and levocetirizine in the treatment of nasal congestion in patients with allergic rhinitis
|
Bachert, Claus |
|
2009 |
31 |
Part 1 |
p. 921-944 24 p. |
artikel |
17 |
Arterial wave reflection during antihypertensive therapy with barnidipine: A 6-month, open-label study using an integrated cardiovascular ultrasound approach in patients with newly diagnosed hypertension
|
Palombo, Carlo |
|
2009 |
31 |
Part 1 |
p. 2873-2885 13 p. |
artikel |
18 |
A safety review of topical bovine thrombin-induced generation of antibodies to bovine proteins
|
Ofosu, Frederick A. |
|
2009 |
31 |
Part 1 |
p. 679-691 13 p. |
artikel |
19 |
A single-center, open-label, one-sequence study of dalcetrapib coadministered with ketoconazole, and an in vitro study of the S-methyl metabolite of dalcetrapib
|
Derks, Michael |
|
2009 |
31 |
Part 1 |
p. 586-599 14 p. |
artikel |
20 |
A single-dose, three-period, six-sequence crossover study comparing the bioavailability of solution, suspension, and enteric-coated tablets of magnesium valproate in healthy Mexican volunteers under fasting conditions
|
Marcelín-Jiménez, Gabriel |
|
2009 |
31 |
Part 1 |
p. 2002-2011 10 p. |
artikel |
21 |
Association between previous health care use and initiation of inhaled corticosteroid and long-acting β2-adrenergic agonist combination therapy among US patients with asthma
|
Blanchette, Christopher M. |
|
2009 |
31 |
Part 1 |
p. 2574-2583 10 p. |
artikel |
22 |
Bendamustine for the treatment of chronic lymphocytic leukemia and rituximab-refractory, indolent B-cell non-hodgkin lymphoma
|
Dennie, Trevor W. |
|
2009 |
31 |
Part 1 |
p. 2290-2311 22 p. |
artikel |
23 |
Besifloxacin ophthalmic suspension 0.6% in patients with bacterial conjunctivitis: A multicenter, prospective, randomized, double-masked, vehicle-controlled, 5-day efficacy and safety study
|
Karpecki, Paul |
|
2009 |
31 |
Part 1 |
p. 514-526 13 p. |
artikel |
24 |
Bioavailability and bioequivalence of two oral formulations of alendronate sodium 70 mg: An open-label, randomized, two-period crossover comparison in healthy Korean adult male volunteers
|
Rhim, Si-Youn |
|
2009 |
31 |
Part 1 |
p. 1037-1045 9 p. |
artikel |
25 |
Bioavailability of two oral formulations of a single dose of levofloxacin 500 mg: An open-label, randomized, two-period crossover comparison in healthy mexican volunteers
|
Galan-Herrera, Juan Francisco |
|
2009 |
31 |
Part 1 |
p. 1796-1803 8 p. |
artikel |
26 |
Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): Single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects
|
Palma-Aguirre, Jose Antonio |
|
2009 |
31 |
Part 1 |
p. 399-410 12 p. |
artikel |
27 |
Bioequivalence and tolerability of two clopidogrel salt preparations, besylate and bisulfate: A randomized, open-label, crossover study in healthy Korean male subjects
|
Kim, Sung-Doo |
|
2009 |
31 |
Part 1 |
p. 793-803 11 p. |
artikel |
28 |
Bioequivalence of a single 10-mg dose of finasteride 5-mg oral disintegrating tablets and standard tablets in healthy adult male Han Chinese volunteers: A randomized sequence, open-label, two-way crossover study
|
Chen, Li |
|
2009 |
31 |
Part 1 |
p. 2242-2248 7 p. |
artikel |
29 |
Bioequivalence of generic and branded subcutaneous enoxaparin: A single-dose, randomized-sequence, open-label, two-period crossover study in healthy Chinese male subjects
|
Feng, Limin |
|
2009 |
31 |
Part 1 |
p. 1559-1567 9 p. |
artikel |
30 |
Bioequivalence of single 100-mg doses of two oral formulations of topiramate: An open-label, randomized-sequence, two-period crossover study in healthy adult male Mexican volunteers
|
Piñeyro-López, Alfredo |
|
2009 |
31 |
Part 1 |
p. 411-417 7 p. |
artikel |
31 |
Bioequivalence of two film-coated tablets of imatinib mesylate 400 mg: A randomized, open-label, single-dose, fasting, two-period, two-sequence crossover comparison in healthy male South American volunteers
|
Parrillo-Campiglia, Susana |
|
2009 |
31 |
Part 1 |
p. 2224-2232 9 p. |
artikel |
32 |
Bioequivalence of two formulations of glucosamine sulfate 500-mg capsules in healthy male chinese volunteers: An open-label, randomized-sequence, single-dose, fasting, two-way crossover study
|
Zhu, YuBing |
|
2009 |
31 |
Part 1 |
p. 1551-1558 8 p. |
artikel |
33 |
Bioequivalence of zonisamide orally dispersible tablet and immediate-release capsule formulations: Results from two open-label, randomized-sequence, single-dose, two-period, two-treatment crossover studies in healthy male volunteers
|
Maanen, Rob van |
|
2009 |
31 |
Part 1 |
p. 1244-1255 12 p. |
artikel |
34 |
Blood pressure-lowering effects of extended-release niacin alone and extended-release niacin/laropiprant combination: A post hoc analysis of a 24-week, placebo-controlled trial in dyslipidemic patients
|
Bays, Harold E. |
|
2009 |
31 |
Part 1 |
p. 115-122 8 p. |
artikel |
35 |
Celecoxib in the treatment of primary dysmenorrhea: Results from two randomized, double-blind, active- and placebo-controlled, crossover studies
|
Daniels, Stephen |
|
2009 |
31 |
Part 1 |
p. 1192-1208 17 p. |
artikel |
36 |
Changes in physicians' practice of prescribing cyclooxygenase-2 inhibitor after market withdrawal of rofecoxib: A retrospective study of physician-patient pairs in Taiwan
|
Hsiao, Fei-Yuan |
|
2009 |
31 |
Part 1 |
p. 2618-2627 10 p. |
artikel |
37 |
Clinically significant drug—drug interactions between oral anticancer agents and nonanticancer agents: A delphi survey of oncology pharmacists
|
Chan, Alexandre |
|
2009 |
31 |
Part 1 |
p. 2379-2386 8 p. |
artikel |
38 |
Comparative clinical trial of S-adenosylmethionine versus nabumetone for the treatment of knee osteoarthritis: An 8-week, multicenter, randomized, double-blind, double-dummy, Phase IV study in Korean patients
|
Kim, Jinhyun |
|
2009 |
31 |
Part 1 |
p. 2860-2872 13 p. |
artikel |
39 |
Comparative pharmacokinetic evaluation of two formulations of bicalutamide 50-mg tablets: An open-label, randomized-sequence, single-dose, two-period crossover study in healthy Korean male volunteers
|
Lee, SeungHwan |
|
2009 |
31 |
Part 1 |
p. 3000-3008 9 p. |
artikel |
40 |
Comparison of insulin detemir and insulin glargine in a basal—bolus regimen, with insulin aspart as the mealtime insulin, in patients with type 1 diabetes: A 52-week, multinational, randomized, open-label, parallel-group, Treat-to-Target noninferiority trial
|
Heller, Simon |
|
2009 |
31 |
Part 1 |
p. 2086-2097 12 p. |
artikel |
41 |
Comparison of temsirolimus pharmacokinetics in patients with renal cell carcinoma not receiving dialysis and those receiving hemodialysis: A case series
|
Lunardi, Gianluigi |
|
2009 |
31 |
Part 1 |
p. 1812-1819 8 p. |
artikel |
42 |
Comparison of the effect of antibiotic treatment on the possibility of diagnosing invasive pneumococcal disease by culture or molecular methods: A prospective, observational study of children and adolescents with proven pneumococcal infection
|
Resti, Massimo |
|
2009 |
31 |
Part 1 |
p. 1266-1273 8 p. |
artikel |
43 |
Comparison of the effects of once-monthly versus once-daily risedronate in postmenopausal osteoporosis: A phase II, 6-month, multicenter, randomized, double-blind, active-controlled, dose-ranging study
|
Ste-Marie, Louis-Georges |
|
2009 |
31 |
Part 1 |
p. 272-285 14 p. |
artikel |
44 |
Comparison of the efficacy and safety of arformoterol 15 μg twice daily and arformoterol 30 μg once daily in COPD: A single-dose, multicenter, randomized, modified-blind, two-way crossover study
|
Panettieri Jr., Reynold A. |
|
2009 |
31 |
Part 1 |
p. 1716-1723 8 p. |
artikel |
45 |
Comparison of the pharmacokinetics of sulfamethoxazole in male chinese volunteers at low altitude and acute exposure to high altitude versus subjects living chronically at high altitude: An open-label, controlled, prospective study
|
Li, Xiang-Yang |
|
2009 |
31 |
Part 1 |
p. 2744-2754 11 p. |
artikel |
46 |
Comparison of the pharmacokinetics of ticlopidine between administration of a combined fixed-dose tablet formulation of ticlopidine 250 mg/Ginkgo extract 80 mg, and concomitant administration of ticlopidine 250-mg and ginkgo extract 80-mg tablets: An open-label, two-treatment, single-dose, randomized-sequence crossover study in healthy Korean male volunteers
|
Kim, Tae-Eun |
|
2009 |
31 |
Part 1 |
p. 2249-2257 9 p. |
artikel |
47 |
Completeness of retail pharmacy claims data: Implications for pharmacoepidemiologic studies and pharmacy practice in elderly patients
|
Polinski, Jennifer M. |
|
2009 |
31 |
Part 1 |
p. 2048-2059 12 p. |
artikel |
48 |
Cost-effectiveness analysis of micafungin versus fluconazole for prophylaxis of invasive fungal infections in patients undergoing hematopoietic stem cell transplantation in Korea
|
Sohn, Hyun Soon |
|
2009 |
31 |
Part 1 |
p. 1105-1115 11 p. |
artikel |
49 |
Cost-effectiveness of pegfilgrastim versus filgrastim primary prophylaxis in women with early-stage breast cancer receiving chemotherapy in the united states
|
Lyman, Gary H. |
|
2009 |
31 |
Part 1 |
p. 1092-1104 13 p. |
artikel |
50 |
Cost-effectiveness of pentostatin compared with cladribine in the management of hairy cell leukemia in the United Kingdom
|
Guest, Julian F. |
|
2009 |
31 |
Part 1 |
p. 2398-2415 18 p. |
artikel |
51 |
Cost-effectiveness of quetiapine plus mood stabilizers compared with mood stabilizers alone in the maintenance therapy of bipolar I disorder: Results of a markov model analysis
|
Fajutrao, Liberty |
|
2009 |
31 |
Part 1 |
p. 1456-1468 13 p. |
artikel |
52 |
Cost-minimization analysis of sequence changes between FOLFIRI and FOLFOX6 therapy for advanced colorectal cancer in Japan
|
Miyazaki, Yoshiko |
|
2009 |
31 |
Part 1 |
p. 2433-2441 9 p. |
artikel |
53 |
Cost-related prescription nonadherence in the united states and Canada: A system-level comparison using the 2007 international health policy survey in seven countries
|
Kennedy, Jae |
|
2009 |
31 |
Part 1 |
p. 213-219 7 p. |
artikel |
54 |
Degarelix: A gonadotropin-releasing hormone antagonist for the management of prostate cancer
|
Steinberg, Michael |
|
2009 |
31 |
Part 1 |
p. 2312-2331 20 p. |
artikel |
55 |
Diclofenac potassium liquid-filled soft gelatin capsules in the management of patients with postbunionectomy pain: A phase III, multicenter, randomized, double-blind, placebo-controlled study conducted over 5 days
|
Riff, Dennis S. |
|
2009 |
31 |
Part 1 |
p. 2072-2085 14 p. |
artikel |
56 |
Differences in annual medication costs and rates of dosage increase between tumor necrosis factor-antagonist therapies for rheumatoid arthritis in a managed care population
|
Ollendorf, Daniel A. |
|
2009 |
31 |
Part 1 |
p. 825-835 11 p. |
artikel |
57 |
Dose accuracy and durability of the NovoPen® 4 insulin delivery device before and after simulation of 5 years of use and under various stress conditions
|
Kristensen, Carsten M. |
|
2009 |
31 |
Part 1 |
p. 2819-2823 5 p. |
artikel |
58 |
Drug treatment of paraphilic and nonparaphilic sexual disorders
|
Guay, David R.P. |
|
2009 |
31 |
Part 1 |
p. 1-31 31 p. |
artikel |
59 |
Economic evaluation of dabigatran etexilate for the prevention of venous thromboembolism after total knee and hip replacement surgery
|
Wolowacz, Sorrel E. |
|
2009 |
31 |
Part 1 |
p. 194-212 19 p. |
artikel |
60 |
Economic outcomes in patients diagnosed with systemic lupus erythematosus with versus without nephritis: Results from an analysis of data from a US claims database
|
Pelletier, Elise M. |
|
2009 |
31 |
Part 1 |
p. 2653-2664 12 p. |
artikel |
61 |
Effectiveness and tolerability of colesevelam hydrochloride for bile-acid malabsorption in patients with cancer: A retrospective chart review and patient questionnaire
|
Wedlake, Linda |
|
2009 |
31 |
Part 1 |
p. 2549-2558 10 p. |
artikel |
62 |
Effectiveness and tolerability of pharmacologic and combined interventions for reducing injection pain during routine childhood immunizations: Systematic review and meta-analyses
|
Shah, Vibhuti |
|
2009 |
31 |
Part 1 |
p. S104-S151 48 p. |
artikel |
63 |
Effectiveness of hydralazine/isosorbide dinitrate in racial/ethnic subgroups with heart failure
|
Hammermeister, Karl E. |
|
2009 |
31 |
Part 1 |
p. 632-643 12 p. |
artikel |
64 |
Effect of agalsidase alfa replacement therapy on fabry disease—related hypertrophic cardiomyopathy: A 12- to 36-month, retrospective, blinded echocardiographic pooled analysis
|
Kampmann, Christoph |
|
2009 |
31 |
Part 1 |
p. 1966-1976 11 p. |
artikel |
65 |
Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion
|
Raz, Itamar |
|
2009 |
31 |
Part 1 |
p. 980-987 8 p. |
artikel |
66 |
Effect of multidrug resistance gene-1 (ABCB1) polymorphisms on the single-dose pharmacokinetics of cloxacillin in healthy adult Chinese men
|
Yin, Ophelia Q.P. |
|
2009 |
31 |
Part 1 |
p. 999-1006 8 p. |
artikel |
67 |
Effect of the CYP3A inhibitor ketoconazole on the pharmacokinetics and pharmacodynamics of bortezomib in patients with advanced solid tumors: A prospective, multicenter, open-label, randomized, two-way crossover drug—drug interaction study
|
Venkatakrishnan, Karthik |
|
2009 |
31 |
Part 1 |
p. 2444-2458 15 p. |
artikel |
68 |
Effects of a concomitant single oral dose of rifampicin on the pharmacokinetics of pravastatin in a two-phase, randomized, single-blind, placebo-controlled, crossover study in healthy Chinese male subjects
|
Deng, Sheng |
|
2009 |
31 |
Part 1 |
p. 1256-1263 8 p. |
artikel |
69 |
Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: A single-center, open-label, prospective, observational study
|
Deal, Eli N. |
|
2009 |
31 |
Part 1 |
p. 299-310 12 p. |
artikel |
70 |
Effects of combination treatment with ketoprofen 100 mg + acetaminophen 1000 mg on postoperative dental pain: A single-dose, 10-hour, randomized, double-blind, active- and placebo-controlled clinical trial
|
Akural, Ethem I. |
|
2009 |
31 |
Part 1 |
p. 560-568 9 p. |
artikel |
71 |
Effects of food and antacids on the pharmacokinetics of eltrombopag in healthy adult subjects: Two single-dose, open-label, randomized-sequence, crossover studies
|
Williams, Daphne D. |
|
2009 |
31 |
Part 1 |
p. 764-776 13 p. |
artikel |
72 |
Effects of food intake on the pharmacokinetics of diclofenac potassium soft gelatin capsules: A single-dose, randomized, two-way crossover study
|
Scallion, Ralph |
|
2009 |
31 |
Part 1 |
p. 2233-2241 9 p. |
artikel |
73 |
Effects of hepatic impairment on the pharmacokinetics of nilotinib: An open-label, single-dose, parallel-group study
|
Yin, Ophelia Q.P. |
|
2009 |
31 |
Part 1 |
p. 2459-2469 11 p. |
artikel |
74 |
Effects of imiglucerase treatment on traumatic fracture and bone and blood abnormalities in a patient with previously untreated type 1 gaucher disease
|
Boiret-Dupré, Nathalie |
|
2009 |
31 |
Part 1 |
p. 2900-2904 5 p. |
artikel |
75 |
Effects of intravenous patient-controlled analgesia with buprenorphine and morphine alone and in combination during the first 12 postoperative hours: A randomized, double-blind, four-arm trial in adults undergoing abdominal surgery
|
Oifa, Stanislav |
|
2009 |
31 |
Part 1 |
p. 527-541 15 p. |
artikel |
76 |
Effects of oral posaconazole on the pharmacokinetic properties of oral and intravenous midazolam: A phase I, randomized, open-label, crossover study in healthy volunteers
|
Krishna, Gopal |
|
2009 |
31 |
Part 1 |
p. 286-298 13 p. |
artikel |
77 |
Effects of pitavastatin on cerebral blood flow
|
Horimoto, Yoshihiko |
|
2009 |
31 |
Part 1 |
p. 575-579 5 p. |
artikel |
78 |
Effects of treatment with etizolam 0.5 mg BID on cognitive performance: A 3-week, multicenter, randomized, double-blind, placebo-controlled, two-treatment, three-period, noninferiority crossover study in patients with anxiety disorder
|
De Candia, Maria Pia |
|
2009 |
31 |
Part 1 |
p. 2851-2859 9 p. |
artikel |
79 |
Efficacy and safety of low-dose transdermal buprenorphine patches (5, 10, and 20 μg/h) versus prolonged-release tramadol tablets (75, 100, 150, and 200 mg) in patients with chronic osteoarthritis pain: A 12-week, randomized, open-label, controlled, parallel-group noninferiority study
|
Karlsson, Mats |
|
2009 |
31 |
Part 1 |
p. 503-513 11 p. |
artikel |
80 |
Efficacy and tolerability of nebivolol monotherapy by baseline systolic blood pressure: A retrospective analysis of pooled data from two multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group, dose-ranging studies in patients with mild to moderate essential hypertension
|
Germino, F. Wilford |
|
2009 |
31 |
Part 1 |
p. 1946-1956 11 p. |
artikel |
81 |
Efficacy and tolerability of once-monthly oral ibandronate (150 mg) and once-weekly oral alendronate (70 mg): Additional results from the monthly oral therapy with ibandronate for osteoporosis intervention (MOTION) study
|
Emkey, Ronald |
|
2009 |
31 |
Part 1 |
p. 751-761 11 p. |
artikel |
82 |
Efficacy of a single dose of live attenuated influenza vaccine in previously unvaccinated children: A post hoc analysis of three studies of children aged 2 to 6 years
|
Block, Stan L. |
|
2009 |
31 |
Part 1 |
p. 2140-2147 8 p. |
artikel |
83 |
Efficacy of roxithromycin in adult patients with rheumatoid arthritis who had not received disease-modifying antirheumatic drugs: A 3-month, randomized, double-blind, placebo-controlled trial
|
Ogrendik, Mesut |
|
2009 |
31 |
Part 1 |
p. 1754-1764 11 p. |
artikel |
84 |
Emerging therapeutic strategies for the treatment of fabry disease
|
Edmunds, Tim |
|
2009 |
31 |
Part 1 |
p. S26-S27 2 p. |
artikel |
85 |
Estimated annual direct expenditures in the united states as a result of inappropriate hypertension treatment according to national treatment guidelines
|
Balu, Sanjeev |
|
2009 |
31 |
Part 1 |
p. 1581-1594 14 p. |
artikel |
86 |
Estimates of pediatric medication use in the United States: Current abilities and limitations
|
Lasky, Tamar |
|
2009 |
31 |
Part 1 |
p. 436-445 10 p. |
artikel |
87 |
Etravirine: A second-generation nonnucleoside reverse transcriptase inhibitor (NNRTI) active against NNRTI-resistant strains of HIV
|
Schiller, Daryl S. |
|
2009 |
31 |
Part 1 |
p. 692-704 13 p. |
artikel |
88 |
Evaluation of the dose—response relationship of aliskiren, a direct renin inhibitor, in an 8-week, multicenter, randomized, double-blind, parallel-group, placebo-controlled study in adult patients with stage 1 or 2 essential hypertension
|
Puig, Juan G. |
|
2009 |
31 |
Part 1 |
p. 2839-2850 12 p. |
artikel |
89 |
Exenatide added to insulin therapy: A retrospective review of clinical practice over two years in an academic endocrinology outpatient setting
|
Yoon, Nancy M. |
|
2009 |
31 |
Part 1 |
p. 1511-1523 13 p. |
artikel |
90 |
First-year treatment adherence among outpatients initiating antihypertensive medication in Korea: Results of a retrospective claims review
|
Sung, Si-Kyung |
|
2009 |
31 |
Part 1 |
p. 1309-1320 12 p. |
artikel |
91 |
Gabapentin for the treatment of hot flashes in women with natural or tamoxifen-induced menopause: A systematic review and meta-analysis
|
Toulis, Konstantinos A. |
|
2009 |
31 |
Part 1 |
p. 221-235 15 p. |
artikel |
92 |
Health economic comparison between continuous subcutaneous insulin infusion and multiple daily injections of insulin for the treatment of adult type 1 diabetes in Canada
|
Charles, Meaghan E.St. |
|
2009 |
31 |
Part 1 |
p. 657-667 11 p. |
artikel |
93 |
High-dose estrogen as salvage hormonal therapy for highly refractory metastatic breast cancer: A retrospective chart review
|
Mahtani, Reshma L. |
|
2009 |
31 |
Part 1 |
p. 2371-2378 8 p. |
artikel |
94 |
Identification of patients receiving peritoneal dialysis using health insurance claims data
|
Berger, Ariel |
|
2009 |
31 |
Part 1 |
p. 1321-1334 14 p. |
artikel |
95 |
Inadequate pain management during routine childhood immunizations: The nerve of it
|
Taddio, Anna |
|
2009 |
31 |
Part 1 |
p. S152-S167 16 p. |
artikel |
96 |
Influence of alcohol on the hemodynamic effects and pharmacokinetic properties of mirodenafil: A single-dose, randomized-sequence, open-label, crossover study in healthy male volunteers in Korea
|
Kim, Bo-Hyung |
|
2009 |
31 |
Part 1 |
p. 1234-1243 10 p. |
artikel |
97 |
Lapatinib: A small-molecule inhibitor of epidermal growth factor receptor and human epidermal growth factor receptor—2 tyrosine kinases used in the treatment of breast cancer
|
Tevaarwerk, Amye J. |
|
2009 |
31 |
Part 1 |
p. 2332-2348 17 p. |
artikel |
98 |
Latest data on Genz-112638, an investigational oral therapy for type 1 Gaucher disease: Phase II clinical trial results after 1 year of treatment
|
Lukina, Elena |
|
2009 |
31 |
Part 1 |
p. S194-S195 2 p. |
artikel |
99 |
Lost in translation: Differences in antimicrobial indication approval policies between the United States and Europe
|
Pappas, Georgios |
|
2009 |
31 |
Part 1 |
p. 1595-1603 9 p. |
artikel |
100 |
Low doses of transdermal buprenorphine in opioid-naive patients with cancer pain: A 4-week, nonrandomized, open-label, uncontrolled observational study
|
Mercadante, Sebastiano |
|
2009 |
31 |
Part 1 |
p. 2134-2138 5 p. |
artikel |
101 |
Management of refractory essential thrombocythemia with anagrelide in a patient undergoing hemodialysis
|
Mesquita, Maria do Carmo Filomena |
|
2009 |
31 |
Part 1 |
p. 2559-2564 6 p. |
artikel |
102 |
Membrane lipids and degenerative lysosomal storage disorders
|
Sandhoff, Konrad |
|
2009 |
31 |
Part 1 |
p. S179-S180 2 p. |
artikel |
103 |
Modafinil for the treatment of hypersomnia associated with myotonic muscular dystrophy in adults: A multicenter, prospective, randomized, double-blind, placebo-controlled, 4-week trial
|
Orlikowski, David |
|
2009 |
31 |
Part 1 |
p. 1765-1773 9 p. |
artikel |
104 |
Model-based simulation to explore the cost-effectiveness of following practice guidelines for triglyceride and low-density lipoprotein cholesterol control among patients with diabetes mellitus and mixed dyslipidemia
|
Sorensen, Sonja V. |
|
2009 |
31 |
Part 1 |
p. 862-879 18 p. |
artikel |
105 |
Modeling the impact of a new vaccine on pneumococcal and nontypable Haemophilus influenzae diseases: A new simulation model
|
De Wals, Philippe |
|
2009 |
31 |
Part 1 |
p. 2152-2169 18 p. |
artikel |
106 |
Modified visual analog scale symptom-intensity and overall-bother measures for the assessment of symptoms in studies of pharmacologic stress agents
|
Harding, Gale |
|
2009 |
31 |
Part 1 |
p. 889-901 13 p. |
artikel |
107 |
Nebivolol: A third-generation β-blocker for hypertension
|
Cheng, Judy W.M. |
|
2009 |
31 |
Part 1 |
p. 447-462 16 p. |
artikel |
108 |
Neutralization of α2-antiplasmin by microplasmin: A randomized, double-blind, placebo-controlled, ascending-dose study in healthy male volunteers
|
Pakola, Steve |
|
2009 |
31 |
Part 1 |
p. 1688-1706 19 p. |
artikel |
109 |
Nilotinib for imatinib-resistant or -intolerant chronic myeloid leukemia in chronic phase, accelerated phase, or blast crisis: A single- and multiple-dose, open-label pharmacokinetic study in Chinese patients
|
Zhou, Li |
|
2009 |
31 |
Part 1 |
p. 1568-1575 8 p. |
artikel |
110 |
N-of-1 double-blind, randomized controlled trial of tramadol to treat chronic cough
|
Louly, Priscila Gebrim |
|
2009 |
31 |
Part 1 |
p. 1007-1013 7 p. |
artikel |
111 |
Once-monthly oral ibandronate in postmenopausal osteoporosis: Translation and updated review
|
Rossini, Maurizio |
|
2009 |
31 |
Part 1 |
p. 1497-1510 14 p. |
artikel |
112 |
One-Year assessment of joint procurement of pharmaceuticals in the public health sector in Jordan
|
Al-Abbadi, Ibrahim |
|
2009 |
31 |
Part 1 |
p. 1335-1344 10 p. |
artikel |
113 |
Pattern and predictors of the initiation of biologic agents for the treatment of rheumatoid arthritis in the United States: An analysis using a large observational data bank
|
DeWitt, Esi Morgan |
|
2009 |
31 |
Part 1 |
p. 1871-1880 10 p. |
artikel |
114 |
Pharmacokinetic and bioequivalence comparison between orally disintegrating and conventional tablet formulations of flurbiprofen: A single-dose, randomized-sequence, open-label, two-period crossover study in healthy chinese male volunteers
|
Liu, Yan-Mei |
|
2009 |
31 |
Part 1 |
p. 1787-1795 9 p. |
artikel |
115 |
Pharmacokinetic comparison of a new glimepiride 1-mg + metformin 500-mg combination tablet formulation and a glimepiride 2-mg + metformin 500-mg combination tablet formulation: A single-dose, randomized, open-label, two-period, two-way crossover study in healthy, fasting Korean male volunteers
|
Kim, Bo-Hyung |
|
2009 |
31 |
Part 1 |
p. 2755-2764 10 p. |
artikel |
116 |
Pharmacokinetic, pharmacodynamic, efficacy, and safety data from two randomized, double-blind studies in patients with asthma and an in vitro study comparing two dry-powder inhalers delivering a combination of salmeterol 50 μg and fluticasone propionate 250 μg: Implications for establishing bioequivalence of inhaled products
|
Daley-Yates, Peter T. |
|
2009 |
31 |
Part 1 |
p. 370-385 16 p. |
artikel |
117 |
Pharmacokinetic—pharmacodynamic interaction between nebicapone and controlled-release levodopa/benserazide: A single-center, phase I, double-blind, randomized, placebo-controlled, four-way crossover study in healthy subjects
|
Nunes, Teresa |
|
2009 |
31 |
Part 1 |
p. 2258-2271 14 p. |
artikel |
118 |
Pharmacokinetic properties and bioequivalence of two formulations of arbidol: An open-label, single-dose, randomized-sequence, two-period crossover study in healthy chinese male volunteers
|
Liu, Ming-Yan |
|
2009 |
31 |
Part 1 |
p. 784-792 9 p. |
artikel |
119 |
Pharmacokinetics and bioequivalence of two formulations of rebamipide 100-mg tablets: A randomized, single-dose, two-period, two-sequence crossover study in healthy Korean male volunteers
|
Cho, Hea-Young |
|
2009 |
31 |
Part 1 |
p. 2712-2721 10 p. |
artikel |
120 |
Pharmacokinetics and tolerability of single escalating doses of fampridine sustained-release tablets in patients with multiple sclerosis: A phase I–II, open-label trial
|
Vollmer, Timothy |
|
2009 |
31 |
Part 1 |
p. 2206-2214 9 p. |
artikel |
121 |
Pharmacokinetics and tolerability of single escalating doses of gabapentin enacarbil: A randomized-sequence, double-blind, placebo-controlled crossover study in healthy volunteers
|
Lal, Ritu |
|
2009 |
31 |
Part 1 |
p. 1776-1786 11 p. |
artikel |
122 |
Pharmacokinetics, bioequivalence, tolerability, and effects on platelet counts of two formulations of anagrelide in healthy volunteers and patients with thrombocythemia associated with chronic myeloproliferation
|
Petrides, Petro E. |
|
2009 |
31 |
Part 1 |
p. 386-398 13 p. |
artikel |
123 |
Pharmacokinetics of a Once-Daily extended-release formulation of pramipexole in healthy male volunteers: Three studies
|
Jenner, Peter |
|
2009 |
31 |
Part 1 |
p. 2698-2711 14 p. |
artikel |
124 |
Pharmacokinetics of ciclesonide and desisobutyryl ciclesonide after administration via aqueous nasal spray or hydrofluoroalkane nasal aerosol compared with orally inhaled ciclesonide: An open-label, single-dose, three-period crossover study in healthy volunteers
|
Nave, Ruediger |
|
2009 |
31 |
Part 1 |
p. 2988-2999 12 p. |
artikel |
125 |
Pharmacokinetics of conivaptan hydrochloride, a vasopressin V1A/V2-receptor antagonist, in patients with euvolemic or hypervolemic hyponatremia and with or without congestive heart failure from a prospective, 4-day open-label study
|
Mao, Zhongping Lily |
|
2009 |
31 |
Part 1 |
p. 1542-1550 9 p. |
artikel |
126 |
Pharmacokinetics of 14C-radioactivity after oral intake of a single dose of 14C-labeled fampridine (4-aminopyridine) in healthy volunteers
|
Blight, Andrew R. |
|
2009 |
31 |
Part 1 |
p. 328-335 8 p. |
artikel |
127 |
Pharmacokinetics, safety, and tolerability of varenicline in healthy adolescent smokers: A multicenter, randomized, double-blind, placebo-controlled, parallel-group study
|
Faessel, Helene |
|
2009 |
31 |
Part 1 |
p. 177-189 13 p. |
artikel |
128 |
Pharmacokinetic, tolerability, and bioequivalence comparison of three different intravenous formulations of recombinant human erythropoietin in healthy Korean adult male volunteers: An open-label, randomized-sequence, three-treatment, three-way crossover study
|
Cho, Sang-Heon |
|
2009 |
31 |
Part 1 |
p. 1046-1053 8 p. |
artikel |
129 |
Pharmacology and tolerability of a single dose of exenatide in adolescent patients with type 2 diabetes mellitus being treated with metformin: A randomized, placebo-controlled, single-blind, dose-escalation, crossover study
|
Malloy, Jaret |
|
2009 |
31 |
Part 1 |
p. 806-815 10 p. |
artikel |
130 |
Physical interventions and injection techniques for reducing injection pain during routine childhood immunizations: Systematic review of randomized controlled trials and quasi-randomized controlled trials
|
Taddio, Anna |
|
2009 |
31 |
Part 1 |
p. S48-S76 29 p. |
artikel |
131 |
Potential interactions between cilostazol and probucol: A two-part, single-dose, open-label study in healthy Korean male volunteers
|
Kim, Kyu-pyo |
|
2009 |
31 |
Part 1 |
p. 2098-2106 9 p. |
artikel |
132 |
Predictors of medication nonadherence among patients with diabetes in Medicare Part D programs: A retrospective cohort study
|
Yang, Yi |
|
2009 |
31 |
Part 1 |
p. 2178-2188 11 p. |
artikel |
133 |
Probability of pharmacodynamic target attainment with standard and prolonged-infusion antibiotic regimens for empiric therapy in adults with hospital-acquired pneumonia
|
Kim, Aryun |
|
2009 |
31 |
Part 1 |
p. 2765-2778 14 p. |
artikel |
134 |
Psychological interventions for reducing pain and distress during routine childhood immunizations: A systematic review
|
Chambers, Christine T. |
|
2009 |
31 |
Part 1 |
p. S77-S103 27 p. |
artikel |
135 |
Relative bioavailability of generic and branded 250-mg and 500-mg oral chlorphenesin carbamate tablets in healthy Korean volunteers: A single-dose, randomized-sequence, open-label, two-period crossover trial
|
Yu, Ji-young |
|
2009 |
31 |
Part 1 |
p. 2735-2743 9 p. |
artikel |
136 |
Results of a cross-sectional survey about lipid-management practices among cardiologists in Pakistan: Assessment of adherence to published treatment guidelines
|
Gowani, Saqib A. |
|
2009 |
31 |
Part 1 |
p. 1604-1614 11 p. |
artikel |
137 |
Results of a Markov model analysis to assess the cost-effectiveness of a single tablet of fixed-dose amlodipine and atorvastatin for the primary prevention of cardiovascular disease in Korea
|
Liew, Danny |
|
2009 |
31 |
Part 1 |
p. 2189-2203 15 p. |
artikel |
138 |
Results of a Markov model analysis to assess the cost-effectiveness of statin therapy for the primary prevention of cardiovascular disease in Korea: The Korean Individual-Microsimulation Model for Cardiovascular Health Interventions
|
Kang, Hye-Young |
|
2009 |
31 |
Part 1 |
p. 2919-2930 12 p. |
artikel |
139 |
Results of a retrospective, observational pilot study using electronic medical records to assess the prevalence and characteristics of patients with resistant hypertension in an ambulatory care setting
|
McAdam-Marx, Carrie |
|
2009 |
31 |
Part 1 |
p. 1116-1123 8 p. |
artikel |
140 |
Results of a single-center, single-dose, randomized-sequence, open-label, two-way crossover bioequivalence study of two formulations of valsartan 160-mg tablets in healthy volunteers under fasting conditions
|
Spínola, Ana Cristina Franco |
|
2009 |
31 |
Part 1 |
p. 1992-2001 10 p. |
artikel |
141 |
Results of a thematic analysis to explore the experiences of patients with schizophrenia taking antipsychotic medication
|
Rofail, Diana |
|
2009 |
31 |
Part 1 |
p. 1488-1496 9 p. |
artikel |
142 |
Retrospective claims study of fluticasone propionate/salmeterol fixed-dose combination use as initial asthma controller therapy in children despite guideline recommendations
|
Friedman, Howard S. |
|
2009 |
31 |
Part 1 |
p. 1056-1063 8 p. |
artikel |
143 |
Romiplostim in chronic immune thrombocytopenic purpura
|
Cersosimo, Robert J. |
|
2009 |
31 |
Part 1 |
p. 1887-1907 21 p. |
artikel |
144 |
Self-reported sedation profile of immediate-release quetiapine fumarate compared with extended-release quetiapine fumarate during dose initiation: A randomized, double-blind, crossover study in healthy adult subjects
|
Datto, Catherine |
|
2009 |
31 |
Part 1 |
p. 492-502 11 p. |
artikel |
145 |
Severe insulin allergy after percutaneous transluminal coronary angioplasty
|
Wang, Chun |
|
2009 |
31 |
Part 1 |
p. 569-574 6 p. |
artikel |
146 |
Shifting the paradigm toward earlier treatment of multiple sclerosis with interferon beta
|
Comi, Giancarlo |
|
2009 |
31 |
Part 1 |
p. 1142-1157 16 p. |
artikel |
147 |
Short-term adherence to β-blocker therapy among ethnic Chinese patients with hypertension: A cohort study
|
Wong, Martin C.S. |
|
2009 |
31 |
Part 1 |
p. 2170-2177 8 p. |
artikel |
148 |
Short-term tolerability of once-daily timolol hemihydrate 0.5%, timolol maleate in sorbate 0.5%, and generic timolol maleate gel-forming solution 0.5% in glaucoma and/or ocular hypertension: A prospective, randomized, double-masked, active-controlled, three-period crossover pilot study
|
Sonty, Sriram |
|
2009 |
31 |
Part 1 |
p. 2063-2071 9 p. |
artikel |
149 |
Silodosin: A selective α1A-adrenergic receptor antagonist for the treatment of benign prostatic hyperplasia
|
Schilit, Sara |
|
2009 |
31 |
Part 1 |
p. 2489-2502 14 p. |
artikel |
150 |
Steady-state pharmacokinetics and tolerability of orally administered fampridine sustained-Release 10-mg tablets in patients with multiple sclerosis: A 2-week, open-label, follow-up study
|
Vollmer, Timothy |
|
2009 |
31 |
Part 1 |
p. 2215-2223 9 p. |
artikel |
151 |
Tapentadol hydrochloride: A centrally acting oral analgesic
|
Wade, William E. |
|
2009 |
31 |
Part 1 |
p. 2804-2818 15 p. |
artikel |
152 |
The association between class of antipsychotic and rates of hospitalization: Results of a retrospective analysis of data from the 2005 medicare current beneficiary survey
|
Kennedy, Jae |
|
2009 |
31 |
Part 1 |
p. 2931-2939 9 p. |
artikel |
153 |
The effect of pramipexole on mood and motivational symptoms in parkinson's disease: A meta-analysis of placebo-controlled studies
|
Leentjens, Albert F.G. |
|
2009 |
31 |
Part 1 |
p. 89-98 10 p. |
artikel |
154 |
The effects of ketoconazole and rifampicin on the pharmacokinetics of mirodenafil in healthy Korean male volunteers: An open-label, one-sequence, three-period, three-treatment crossover study
|
Shin, Kwang-Hee |
|
2009 |
31 |
Part 1 |
p. 3009-3020 12 p. |
artikel |
155 |
The efficacy and safety profile of lisdexamfetamine dimesylate, a prodrug of d-amphetamine, for the treatment of attention-deficit/hyperactivity disorder in children and adults
|
Najib, Jadwiga |
|
2009 |
31 |
Part 1 |
p. 142-176 35 p. |
artikel |
156 |
The relationship between reduction in low-density lipoprotein cholesterol by statins and reduction in risk of cardiovascular outcomes: An updated meta-analysis
|
Delahoy, Philippa J. |
|
2009 |
31 |
Part 1 |
p. 236-244 9 p. |
artikel |
157 |
The role of patient inexperience in medication discontinuation: A retrospective analysis of medication nonpersistence in seven chronic illnesses
|
Vanelli, Mark |
|
2009 |
31 |
Part 1 |
p. 2628-2652 25 p. |
artikel |
158 |
The thiazolidinediones rosiglitazone and pioglitazone and the risk of coronary heart disease: A retrospective cohort study using a US health insurance database
|
Ziyadeh, Najat |
|
2009 |
31 |
Part 1 |
p. 2665-2677 13 p. |
artikel |
159 |
The value of dividends in health: A call to align stakeholders
|
Nayer, Cyndy |
|
2009 |
31 |
Part 1 |
p. 2689-2696 8 p. |
artikel |
160 |
Time to onset and duration of action of the antihistamine bepotastine besilate ophthalmic solutions 1.0% and 1.5% in allergic conjunctivitis: A phase III, single-center, prospective, randomized, double-masked, placebo-controlled, conjunctival allergen challenge assessment in adults and children
|
Abelson, Mark B. |
|
2009 |
31 |
Part 1 |
p. 1908-1921 14 p. |
artikel |
161 |
Tolerability of teicoplanin in 117 hospitalized adults with previous vancomycin-induced fever, rash, or neutropenia: A retrospective chart review
|
Hung, Yuan-Pin |
|
2009 |
31 |
Part 1 |
p. 1977-1986 10 p. |
artikel |
162 |
Topiramate versus amitriptyline in migraine prevention: A 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs
|
Dodick, David W. |
|
2009 |
31 |
Part 1 |
p. 542-559 18 p. |
artikel |
163 |
Treatment of depression in the elderly: A review of the recent literature on the efficacy of single- versus dual-action antidepressants
|
Mukai, Yuki |
|
2009 |
31 |
Part 1 |
p. 945-961 17 p. |
artikel |
164 |
Two first-in-human, open-label, phase I dose-escalation safety trials of MEDI-528, a monoclonal antibody against interleukin-9, in healthy adult volunteers
|
White, Barbara |
|
2009 |
31 |
Part 1 |
p. 728-740 13 p. |
artikel |
165 |
Unexplained high fever in an elderly patient treated with clonidine, duloxetine, and atorvastatin
|
Kelesidis, Theodoros |
|
2009 |
31 |
Part 1 |
p. 2894-2899 6 p. |
artikel |
166 |
Upper gastrointestinal tolerability of alendronate sodium monohydrate 10 mg once daily in postmenopausal women: A 12-week, randomized, double-blind, placebo-controlled, exploratory study
|
Adachi, Jonathan D. |
|
2009 |
31 |
Part 1 |
p. 1747-1753 7 p. |
artikel |
167 |
Validity of the adherence estimator in the prediction of 9-month persistence with medications prescribed for chronic diseases: A prospective analysis of data from pharmacy claims
|
McHorney, Colleen A. |
|
2009 |
31 |
Part 1 |
p. 2584-2607 24 p. |
artikel |
168 |
Varenicline: A first-line treatment option for smoking cessation
|
Garrison, Gina Daubney |
|
2009 |
31 |
Part 1 |
p. 463-491 29 p. |
artikel |